The Impact of Advanced Practice Clinicians on End of Life Outcomes for Older Adults with Dementia
高级实践临床医生对痴呆症老年人临终结局的影响
基本信息
- 批准号:10341076
- 负责人:
- 金额:$ 48.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-15 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdmission activityAdvance Care PlanningAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaCaregiversCaringCensusesCessation of lifeCharacteristicsClient satisfactionCommunitiesCountryCoupledCross-Sectional StudiesDataDementiaDo Not Resuscitate OrderEffectivenessElderlyEnteral FeedingExposure toFaceFamilyFee-for-Service PlansGeographic stateGoalsHealth PersonnelHealth systemHospitalizationHospitalsIndividualIntensive Care UnitsInterventionKnowledgeLifeLinkLiteratureLocationManaged CareMedicaidMedicalMedically Underserved AreaMedicareMedicare claimMinorityModelingNational Institute on AgingNurse PractitionersNursing HomesOutcomeOutpatientsPalliative CarePatient CarePatientsPersonsPharmaceutical PreparationsPhysician AssistantsPhysiciansPlayPoliciesPopulationPrimary Care PhysicianPrimary Health CareProviderQuality of CareRegulationResearchResourcesRightsRoleSafetySchoolsServicesTestingTrainingWorkacute carebasebeneficiarycare systemscommunity settingdemographicsdesigndual eligibleend of lifeend of life carehealth care service organizationhospice environmentimprovedrecruitreduce symptomsrural underservedskills
项目摘要
ABSTRACT
Individuals with Alzheimer’s disease and related dementias (ADRD) often face hospitalizations and other
burdensome interventions at end of life that could be avoided with better preemptive medical care –
specifically, early recognition and treatment of acute illness, improved advance care planning and palliative
care, and availability of resources to manage acute conditions in the outpatient setting. Nurse practitioners and
physician assistants, collectively known as advanced practice clinicians (APCs), are playing an increasingly
important role in the medical management of older adults in both nursing home and community settings, yet
little is known about how these clinicians influence end of life outcomes for people with ADRD under traditional
fee-for-service Medicare. Additionally, APC scope of practice is governed by state regulations which vary
considerably and it is unknown how these regulations impact the provision of end of life care to people with
ADRD, particularly those living in rural or medically underserved areas. The long-term goal of this research is
to develop evidence that will inform workforce planning and policy efforts to provide high quality care to people
with ADRD at end of life. Our central hypotheses are that APCs provide services to vulnerable sub-populations
of people with ADRD who may otherwise have poor access to quality end of life care; and that the involvement
of APCs in care reduces the likelihood of being exposed to burdensome interventions at end of life. To test
these hypotheses, we propose a cross-sectional study using 2015-2018 Medicare claims and administrative
data with the following specific aims: (1) To describe population and state regulatory characteristics associated
with people with ADRD receiving care from APCs at end of life; (2) To evaluate whether APC care is
associated with acute care utilization in the last month of life, death in a hospital, hospice utilization, and
feeding tube placement for people with ADRD; and (3) To evaluate whether the effects of APC care on end of
life outcomes vary across states with different scope of practice regulations. This will be the first study to
examine the impact of APCs on end of life outcomes for individuals with ADRD, or for any population of
Medicare beneficiaries. Findings from this study will inform staffing composition for nursing homes, physician
practices, and other healthcare organizations that care for people with ADRD; provide guidance to state
policymakers who design APC scope of practice regulations; and inform workforce planning, training, and
recruitment efforts for schools and healthcare organizations.
摘要
患有阿尔茨海默病和相关痴呆症(ADRD)的个体经常面临住院治疗和其他疾病。
在生命结束时进行繁重的干预,可以通过更好的先发制人的医疗护理来避免-
具体地说,早期识别和治疗急性疾病、改进预先护理规划和姑息治疗,
护理和资源的可用性,以管理急性条件在门诊设置。执业护士和
医生助理,统称为高级实践临床医生(APC),正在发挥越来越多的作用。
在护理之家和社区环境中老年人的医疗管理中发挥重要作用,但
关于这些临床医生如何影响ADRD患者在传统治疗方案下的生命结局,
按服务收费的医疗保险此外,APC的实践范围受各州法规的管辖,
目前还不清楚这些法规如何影响向患有糖尿病的人提供临终关怀。
ADRD,特别是生活在农村或医疗服务不足地区的人。这项研究的长期目标是
开发证据,为劳动力规划和政策工作提供信息,为人们提供高质量的护理
在生命的尽头,我们的中心假设是APC为弱势亚群体提供服务
ADRD患者可能无法获得高质量的临终关怀;参与
护理中的APC减少了在生命结束时暴露于繁重的干预措施的可能性。测试
这些假设,我们提出了一个横断面研究,使用2015-2018年医疗保险索赔和行政
数据具有以下具体目的:(1)描述与人口和国家监管特征相关的
ADRD患者在生命末期接受APC治疗;(2)评估APC治疗是否
与生命最后一个月的急性护理利用率、医院死亡率、临终关怀利用率以及
ADRD患者的饲管放置;(3)评估APC护理对ADRD结束的影响,
各州的生活结果各不相同,执业条例的范围也各不相同。这将是第一项研究,
检查APC对ADRD个体或任何
医疗保险受益人这项研究的结果将告知养老院的人员组成,医生
实践和其他护理ADRD患者的医疗保健组织;为国家提供指导
设计APC实践法规范围的决策者;并为劳动力规划、培训和
学校和医疗机构的招聘工作。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Socioeconomic Disparities in Community Mobility Reduction and COVID-19 Growth.
- DOI:10.1016/j.mayocp.2020.10.019
- 发表时间:2021-01
- 期刊:
- 影响因子:8.9
- 作者:Ossimetha A;Ossimetha A;Kosar CM;Rahman M
- 通讯作者:Rahman M
Advanced practice clinician care and end-of-life outcomes for community- and nursing home-dwelling Medicare beneficiaries with dementia.
为患有痴呆症的社区和疗养院医疗保险受益人提供先进的临床医生护理和临终结果。
- DOI:10.1002/alz.13052
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Oh,Hyesung;White,ElizabethM;Muench,Ulrike;Santostefano,Christopher;Thapa,Bishnu;Kosar,Cyrus;Gadbois,EmilyA;Osakwe,ZainabToteh;Gozalo,Pedro;Rahman,Momotazur
- 通讯作者:Rahman,Momotazur
Assessment of Rural-Urban Differences in Health Care Use and Survival Among Medicare Beneficiaries With Alzheimer Disease and Related Dementia.
- DOI:10.1001/jamanetworkopen.2020.22111
- 发表时间:2020-10-01
- 期刊:
- 影响因子:13.8
- 作者:Rahman M;White EM;Thomas KS;Jutkowitz E
- 通讯作者:Jutkowitz E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Md Momotazur Rahman其他文献
Md Momotazur Rahman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Md Momotazur Rahman', 18)}}的其他基金
Private Equity Expansion in Assisted Living: Implications for Dementia Care
私募股权在辅助生活领域的扩张:对痴呆症护理的影响
- 批准号:
10738928 - 财政年份:2023
- 资助金额:
$ 48.99万 - 项目类别:
Disparity in Incidence and Health Outcomes between Rural and Urban Patients with Alzheimers disease and related disorders
城乡阿尔茨海默病及相关疾病患者的发病率和健康结果差异
- 批准号:
9225408 - 财政年份:2017
- 资助金额:
$ 48.99万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 48.99万 - 项目类别:
Research Grant














{{item.name}}会员




